Authors' reply to: Could statins be a real therapeutic option for the treatment of hepatitis C?

被引：0
|
作者：
Malaguarnera, Michele [2 ]
Vacante, Marco [1 ]
Giordano, Maria [1 ]
Malaguarnera, Mariano [1 ]
Galvano, Fabio [2 ]
Volti, Giovanni Li [2 ]
机构：
[1] Univ Catania, Dept Internal Med & Syst Dis, Catania, Italy
[2] Univ Catania, Dept Biochem Med Chem & Mol Biol, Catania, Italy
来源：
HEPATITIS MONTHLY | 2011年 / 11卷 / 07期
关键词：
Hepatitis C; NAFLD; Ribavirin; Interferon; FATTY LIVER-DISEASE; PEGYLATED INTERFERON; RIBAVIRIN; ALPHA; FLUVASTATIN; EFFICACY;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：563 / 564
页数：2
相关论文
共 50 条
  • [21] Statins demonstrated to have benefit in treatment of hepatitis C virus
    不详
    FORMULARY, 2007, 42 (07) : 455 - 455
  • [22] Neuropsychiatric impact of hepatitis C on advanced HIV - Reply from the authors
    Ryan, EL
    Dieterich, D
    Morgello, S
    NEUROLOGY, 2005, 64 (04) : 768 - 768
  • [23] Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults-Authors' reply
    Pertzov, B.
    Eliakim-Raz, N.
    Atamna, H.
    Trestioreanu, A. Z.
    Yahav, D.
    Leibovici, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (12) : 1572 - 1573
  • [24] Interferon-α treatment of patients with hepatitis C -: The role of a comprehensive risk-benefit assessment -: The authors' reply
    Raison, CL
    Demetrashvili, M
    Capuron, L
    Miller, AH
    CNS DRUGS, 2005, 19 (08) : 721 - 722
  • [25] Could maintenance topical tacrolimus treatment be regarded as a new therapeutic option in atopic dermatitis?
    Narbutt, Joanna
    Zakrzewski, Marcin
    Lesiak, Aleksandra
    PRZEGLAD DERMATOLOGICZNY, 2009, 96 (03): : 235 - 239
  • [26] Assessment of Outcomes of Hepatitis C Treatment Reply
    Kohli, Anita
    Kottilil, Shyam
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (23): : 2571 - 2571
  • [27] Treatment With Silymarin for Hepatitis C Virus Reply
    Fried, Michael W.
    Hawke, Roy L.
    Reddy, K. Rajender
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (18): : 1857 - 1857
  • [28] Sofosbuvir: A novel treatment option for chronic hepatitis C infection
    Bhatia, Harmeet Kaur
    Singh, Harmanjit
    Grewal, Nipunjot
    Natt, Navreet Kaur
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2014, 5 (04) : 278 - 284
  • [29] Hepatitis C treatment: an incipient therapeutic revolution
    deLemos, Andrew S.
    Chung, Raymond T.
    TRENDS IN MOLECULAR MEDICINE, 2014, 20 (06) : 315 - 321
  • [30] PEGINTERFERON ALFA-2A MONOTHERAPY COULD BE A TREATMENT OPTION FOR CHRONIC HEPATITIS C IN PATIENTS INFECTED WITH HCV GENOTYPE 2
    Takaguchi, Koichi
    Nagono, Tokuya
    Wato, Mosaki
    Bobo, Nobuaki
    Seno, Tomonori
    Inaba, Tomoki
    Watanabe, Seishiro
    Kawoi, Kozo
    HEPATOLOGY, 2008, 48 (04) : 535A - 535A
12345